Loading publications…
The last 5 uploaded publications
Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia A
Antonino Cannavò, Carla Valsecchi, Isabella Garagiola, Roberta Palla, Pier Mannuccio Mannucci, Frits R. Rosendaal, Flora Peyvandi (2016). Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia A. Blood, 129(10), pp. 1245-1250, DOI: 10.1182/blood-2016-06-720086.
Article126 days agoTiming and severity of inhibitor development in recombinant versus plasma‐derived factor VIII concentrates: a SIPPET analysis
Flora Peyvandi, Antonino Cannavò, Isabella Garagiola, Roberta Palla, Pier Mannuccio Mannucci, Frits R. Rosendaal, Amal El‐Beshlawy, Mohsen Saleh Elalfy, Vijay Ramanan, Peyman Eshghi, Suresh Hanagavadi, Ramya Varadarajan, Milad Karimi, Mamta Manglani, Cecil Ross, Guy Young, Tulika Seth, Suneel Apte, Dinesh Nayak, Elena Santagostino, Maria Elisa Mancuso, Adriana C. Sandoval Gonzalez, Johnny Mahlangu, Santiago Bonanad, M. Cerqueira, Nadia P. Ewing, Christoph Male, Tarek Owaidah, Verónica Soto Arellano, Nathan L. Kobrinsky, Suvankar Majumdar, Rosario Garrido, Anupam Sachdeva, Michael A. Simpson, Mathew Thomas, Ezio Zanon, Bülent Antmen, K. Kavakl, Marilyn J. Manco‐Johnson, Mikel Martínez, E. Marzouka, M.G. Mazzucconi, Daniela Neme, A. Palomo Bravo, Rodrigo Aguilera, A. Prezotti, Katharina Schmitt, Brian M. Wicklund, Bülent Zülfikar (2017). Timing and severity of inhibitor development in recombinant versus plasma‐derived factor VIII concentrates: a SIPPET analysis. Journal of Thrombosis and Haemostasis, 16(1), pp. 39-43, DOI: 10.1111/jth.13888.
Article126 days agoFactor VIII products and inhibitor development in previously treated patients with severe or moderately severe hemophilia A: a systematic review
Shermarke Hassan, Antonino Cannavò, Samantha C. Gouw, Frits R. Rosendaal, Johanna G. van der Bom (2018). Factor VIII products and inhibitor development in previously treated patients with severe or moderately severe hemophilia A: a systematic review. Journal of Thrombosis and Haemostasis, 16(6), pp. 1055-1068, DOI: 10.1111/jth.14124.
Article126 days agoPrediction of factor VIII inhibitor development in the SIPPET cohort by mutational analysis and factor VIII antigen measurement
Silvia Spena, Isabella Garagiola, Antonino Cannavò, Mimosa Mortarino, P.M. Mannucci, Frits R. Rosendaal, Flora Peyvandi, Amal El‐Beshlawy, Mohsen Saleh Elalfy, Vijay Ramanan, Peyman Eshghi, Suresh Hanagavadi, Ramya Varadarajan, Milad Karimi, Mamta Manglani, Cecil Ross, George R. Young, Tulika Seth, Suneel Apte, Dinesh Nayak, Elena Santagostino, Maria Elisa Mancuso, Adriana C. Sandoval Gonzalez, Johnny Mahlangu, Santiago Bonanad, Marcos Cerqueira, Nadia P. Ewing, Christoph Male, Tarek Owaidah, Verónica Soto Arellano, Nathan L. Kobrinsky, S. S. Majumdar, Rosario Garrido, Anupam Sachdeva, Michael A. Simpson, Meenu Thomas, Ezio Zanon, Bülent Antmen, Kaan Kavaklı, Marilyn J. Manco‐Johnson, Miguel J. Martínez, E. Marzouka, M.G. Mazzucconi, Daniela Neme, A. Palomo Bravo, Rodrigo Aguilera, A. Prezotti, Katharina Schmitt, Brian M. Wicklund, Bülent Zülfikar (2018). Prediction of factor VIII inhibitor development in the SIPPET cohort by mutational analysis and factor VIII antigen measurement. Journal of Thrombosis and Haemostasis, 16(4), pp. 778-790, DOI: 10.1111/jth.13961.
Article126 days agoRisk Differential in Inhibitor Development in the First Days of Treatment By Product Class: A Sippet Analysis
Flora Peyvandi, Antonino Cannavò, Isabella Garagiola, Roberta Palla, Frits R. Rosendaal, Piermannuccio Mannucci (2016). Risk Differential in Inhibitor Development in the First Days of Treatment By Product Class: A Sippet Analysis. Blood, 128(22), pp. 330-330, DOI: 10.1182/blood.v128.22.330.330.
Article126 days ago